Thrombotic thrombocytopenic purpura: gaining knowledge

Affiliations

¹ Smart State Center of Excellence from Medication Safety and Efficacy, University of South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA. Electronic address: bennettc@sccp.sc.edu.
² USF Health Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Comment

Charles L Bennett et al. Lancet Haematol. 2016 May.

. 2016 May;3(5):e210-1.

doi: 10.1016/S2352-3026(16)30028-X. Epub 2016 Apr 16.

¹ Smart State Center of Excellence from Medication Safety and Efficacy, University of South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA. Electronic address: bennettc@sccp.sc.edu.
² USF Health Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

No abstract available

Comment on

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Mariotte E, et al. Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16. Lancet Haematol. 2016. PMID: 27132698 Clinical Trial.